Nov 25, 2025 06:21AM Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral

Nov 13, 2025 06:43PM Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c

Nov 10, 2025 04:28PM Vor Biopharma (VOR) files for 51M share offering by selling stockholders

Oct 14, 2025 05:10PM Baird Upgrades Vor Biopharma, Inc. (VOR) to Outperform

Oct 7, 2025 10:21AM Vor Biopharma (VOR) 30-day option implied volatility at 138 amid wide price movement

Sep 24, 2025 05:00PM Vor Biopharma (VOR) files for 51M share offering by selling stockholders

Sep 24, 2025 02:36AM Stifel Upgrades Vor Biopharma, Inc. (VOR) to Buy

Sep 23, 2025 08:00AM Vor Bio names Navid Khan as chief medical affairs officer

Sep 15, 2025 05:58AM Vor Biopharma (VOR) call put ratio 1 call to 2.4 puts

Jul 17, 2025 08:30AM Vor Bio names Qing Zuraw chief development officer

Jul 10, 2025 04:00PM Vor Bio names Sandy Mahatme as CFO and chief business officer

Jun 30, 2025 06:42AM H.C. Wainwright Upgrades Vor Biopharma, Inc. (VOR) to Buy

Jun 26, 2025 07:54AM Stifel Reiterates Hold Rating on Vor Biopharma, Inc. (VOR)

Jun 25, 2025 04:50PM Vor Biopharma (VOR) Announces $175 Million Private Placement

Jun 25, 2025 04:46PM Vor Biopharma (VOR) Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

May 9, 2025 12:17AM Stifel Downgrades Vor Biopharma, Inc. (VOR) to Hold

May 8, 2025 04:36PM Baird Downgrades Vor Biopharma, Inc. (VOR) to Neutral

May 8, 2025 09:51AM Jones Trading Downgrades Vor Biopharma, Inc. (VOR) to Hold

May 8, 2025 08:33AM Vor Biopharma (VOR) Announces Exploration of Strategic Alternatives, Winding Down Operations

Mar 24, 2025 05:50AM Citizens JMP Reiterates Market Outperform Rating on Vor Biopharma, Inc. (VOR)

Mar 21, 2025 07:43AM Vor Biopharma, Inc. (VOR) PT Lowered to $5 at Stifel

Mar 20, 2025 04:47PM Vor Biopharma (VOR) Files $350M Mixed Shelf

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview

Jan 21, 2025 04:28PM Vor Biopharma (VOR) Files for 125.71M Share Offering by Selling Stockholders

Jan 8, 2025 09:01AM Vor Biopharma (VOR) Appoints Erez Kalir to its Board

Dec 27, 2024 09:01AM Vor Biopharma (VOR) Announces $55.6M Placement

Dec 9, 2024 07:35AM Vor Biopharma (VOR) Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

Nov 7, 2024 04:25PM Vor Biopharma Inc. (VOR) Reports In-Line Q3 EPS

Sep 30, 2024 07:03AM Vor Biopharma (VOR) Appoints Han Choi as CFO

Sep 6, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on Vor Biopharma, Inc. (VOR)

Sep 6, 2024 05:05AM Baird Reiterates Outperform Rating on Vor Biopharma, Inc. (VOR)

Sep 5, 2024 04:01PM Vor Biopharma (VOR): New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

Aug 8, 2024 04:19PM Vor Biopharma Inc. (VOR) Tops Q2 EPS by 1c